The present proposal is designed to continue ongoing work in our laboratory directed at exploring the neuronal pathways and neurochemical substrates involved in opiate reinforcement and dependence. The overall hypothesis being tested is that a common neural substrate mediates the reinforcing and dependence inducing properties of opiates relevant to drug abuse. Work in the previous funding period has led to a focus on the region of the nucleus accumbens and its connections in the positive reinforcing effects of opiates and in the negative reinforcing effects of opiate withdrawal. The experiments outlined in the present proposal will identify the neural sites important for the reinforcing properties of opiates in dependent rats and compare this information to that already generated in the non-dependent animal. Neural sites important for various opiate withdrawal responses including response-suppression aversion and unconditioned behavior will be identified using local intracerebral injections of a quaternary derivative of naloxone in dependent rats. Significant evidence exists to show that rats, monkeys and man show behavioral and physiological manifestation of a conditioned opiate withdrawal where previously neutral stimuli that have been paired with a state of precipitated withdrawal response. An attempt will be made to produce a rat model of conditioned withdrawal and to define the motivational properties of such conditioned stimuli in drug self- administration. Finally the role of afferents to the nucleus accumbens in opiate reinforcement and dependence will be examined with a focus on the amygdala accumbens projection. These studies have important implications for our understanding of the neural substrates involved in opiate seeking behavior and the drug abuse process.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004043-06
Application #
3209042
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1986-05-01
Project End
1994-04-30
Budget Start
1991-05-01
Budget End
1992-04-30
Support Year
6
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Schmeichel, Brooke E; Herman, Melissa A; Roberto, Marisa et al. (2017) Hypocretin Neurotransmission Within the Central Amygdala Mediates Escalated Cocaine Self-administration and Stress-Induced Reinstatement in Rats. Biol Psychiatry 81:606-615
Cui, Changhai; Noronha, Antonio; Warren, Kenneth R et al. (2015) Brain pathways to recovery from alcohol dependence. Alcohol 49:435-52
Schmeichel, Brooke E; Barbier, Estelle; Misra, Kaushik K et al. (2015) Hypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats. Neuropsychopharmacology 40:1123-9
Park, Paula E; Schlosburg, Joel E; Vendruscolo, Leandro F et al. (2015) Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia. Addict Biol 20:275-84
Wade, Carrie L; Vendruscolo, Leandro F; Schlosburg, Joel E et al. (2015) Compulsive-like responding for opioid analgesics in rats with extended access. Neuropsychopharmacology 40:421-8
Koob, George F; Buck, Cara L; Cohen, Ami et al. (2014) Addiction as a stress surfeit disorder. Neuropharmacology 76 Pt B:370-82
Buck, Cara L; Vendruscolo, Leandro F; Koob, George F et al. (2014) Dopamine D1 and ?-opioid receptor antagonism blocks anticipatory 50 kHz ultrasonic vocalizations induced by palatable food cues in Wistar rats. Psychopharmacology (Berl) 231:929-37
Koob, George F (2013) Addiction is a Reward Deficit and Stress Surfeit Disorder. Front Psychiatry 4:72
Park, Paula E; Vendruscolo, Leandro F; Schlosburg, Joel E et al. (2013) Corticotropin-releasing factor (CRF) and ? 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats. Int J Neuropsychopharmacol 16:1867-75
Edwards, Scott; Koob, George F (2013) Escalation of drug self-administration as a hallmark of persistent addiction liability. Behav Pharmacol 24:356-62

Showing the most recent 10 out of 107 publications